Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Microvascular and anti-inflammatory effects of rivaroxaban
2014-001305-41Phase 3Completed
- Sponsor
- GWT-TUD
- Start
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of rivaroxaban in type 2 diabetes mellitus (T2DM) and cardiac morbidity (2 arms), sponsored by GWT-TUD. Started Jun 2014; status: completed.
02
Drugs
rivaroxaban
03
Conditions
type 2 diabetes mellitus (T2DM)cardiac morbidity
Beyond the preview
Go deeper on 2014-001305-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001305-41.